Gufic Biosciences Limited

NSE GUFICBIO.NS

Gufic Biosciences Limited Free Cash Flow Per Share for the year ending March 31, 2024: USD -0.15

Gufic Biosciences Limited Free Cash Flow Per Share is USD -0.15 for the year ending March 31, 2024, a 45.63% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.
  • Gufic Biosciences Limited Free Cash Flow Per Share for the year ending March 31, 2023 was USD -0.27, a -1,364.99% change year over year.
  • Gufic Biosciences Limited Free Cash Flow Per Share for the year ending March 31, 2022 was USD 0.02, a -79.85% change year over year.
  • Gufic Biosciences Limited Free Cash Flow Per Share for the year ending March 31, 2021 was USD 0.11, a 1,281.26% change year over year.
  • Gufic Biosciences Limited Free Cash Flow Per Share for the year ending March 31, 2020 was USD 0.01, a 152.42% change year over year.
Key data
Date Free Cash Flow Per Share Return on Assets (ROA) Return on Equity (ROE) Return on Capital Employed (ROCE)
Market news
Loading...
SV Wall Street
NSE: GUFICBIO.NS

Gufic Biosciences Limited

CEO Mr. Pranav Jayesh Choksi
IPO Date Oct. 19, 2004
Location India
Headquarters SM House
Employees 1,491
Sector Consumers Staples
Industries
Description

Gufic Biosciences Limited engages in manufacture and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, it offers spark, criti care, and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products to more than 20 countries. The company was founded in 1970 and is based in Mumbai, India.

Similar companies

KOPRAN.NS

Kopran Limited

USD 2.10

-2.71%

INDOCO.NS

Indoco Remedies Limited

USD 2.88

1.89%

RPGLIFE.NS

RPG Life Sciences Limited

USD 28.13

1.29%

HIKAL.NS

Hikal Limited

USD 4.09

2.01%

GREENPLY.NS

Greenply Industries Limited

USD 3.23

1.07%

StockViz Staff

February 2, 2025

Any question? Send us an email